Protara Therapeutics, Inc.
Balance Sheet
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Cash & Equivalents | $49.7M | $162.8M | $39.6M | $24.1M | $35.7M | $168.6M | $564.0K | $19.4M |
| Accounts Receivable | — | — | — | — | — | — | — | — |
| Inventory | — | — | — | — | — | — | — | — |
| Total Current Assets | $159.5M | $172.2M | $68.7M | $86.1M | $93.1M | $169.4M | $764.0K | $23.2M |
| Property, Plant & Equipment | $759.0K | $1.0M | $1.3M | $1.6M | $1.7M | $1.2M | $459.0K | $263.0K |
| Goodwill | — | — | — | — | $29.5M | $29.5M | — | — |
| Intangible Assets (Excl. Goodwill) | — | — | — | — | — | — | — | — |
| Total Assets | $209.5M | $181.5M | $79.0M | $113.3M | $172.6M | $203.2M | $1.2M | $23.5M |
| Liabilities | ||||||||
| Accounts Payable | $3.5M | $4.4M | $2.4M | $1.6M | $954.0K | $914.0K | $716.0K | $441.0K |
| Total Current Liabilities | $10.9M | $11.0M | $6.1M | $5.7M | $4.3M | $2.9M | $3.4M | $3.1M |
| Long-Term Debt | — | — | — | — | — | — | — | — |
| Total Liabilities | $13.1M | $14.3M | $10.6M | $11.2M | $10.7M | $3.9M | $3.4M | $3.1M |
| Stockholders' Equity | ||||||||
| Retained Earnings | $-302.4M | $-245.0M | $-200.4M | $-160.0M | $-94.0M | $-46.8M | $-12.8M | $-210.5M |
| Total Stockholders' Equity | $196.4M | $167.1M | $68.3M | $102.1M | $161.9M | $199.2M | $-2.1M | $4.8M |